NCT01546116 - Adefovir and Lamivudine for Entecavir Resistance (ALTER Study) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

February 29, 2012

Study Completion Date

February 28, 2014

Conditions

Chronic Hepatitis B

Interventions

DRUG

ADEFOVIR, LAMIVUDINE

Adefovir/10mg tablet/once a day/52week Lamivudine/100mg tablet/once a day/52week

Trial Locations (9)

Chungbuk National University Hospital, Cheongju-si

Yonsei University Wonju Christian Hospital, Wŏnju

Korea University Ansan Hospital, Ansan

Hallym University, Sacred Heart Hospital, Anyang-si

The Catholic University of Korea, Euijeongbu Saint Mary's Hospital, Euijeongbu

Gachon University Gil Medical Center, Incheon

Inha University Hospital, Incheon

Hallym University, Gangnam Sacred Heart Hospital, Seoul

Korea University Anam Hospital, Seoul